Search Results - Kristian Reich

Refine Results
  1. 1
    The concept of psoriasis as a systemic inflammation: implications for disease management

    The concept of psoriasis as a systemic inflammation: implications for disease management by Kristian Reich

    Published 2012
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Approach to managing patients with nail psoriasis

    Approach to managing patients with nail psoriasis by Kristian Reich

    Published 2009
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Psoriasis – New Insights Into Pathogenesis and Treatment

    Psoriasis – New Insights Into Pathogenesis and Treatment by Ulrich Mrowietz, Kristian Reich

    Published 2009
    Get full text
    Revisão
    Save to List
    Saved in:
  4. 4
    Treatment goals in psoriasis

    Treatment goals in psoriasis by Kristian Reich, Ulrich Mrowietz

    Published 2007
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  5. 5
    In touch with psoriasis: topical treatments and current guidelines

    In touch with psoriasis: topical treatments and current guidelines by G. M. Murphy, Kristian Reich

    Published 2011
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  6. 6
    Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis

    Interleukin‐17A: a unique pathway in immune‐mediated diseases: psoriasis, psoriatic arthritis and rheumatoid arthritis by Bruce Kirkham, Arthur Kavanaugh, Kristian Reich

    Published 2013
    Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Non‐adherence and measures to improve adherence in the topical treatment of psoriasis

    Non‐adherence and measures to improve adherence in the topical treatment of psoriasis by I. Zschocke, Ulrich Mrowietz, Eleni Karakasili, Kristian Reich

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  8. 8
    Nail psoriasis as a severity indicator: results from the PsoReal study

    Nail psoriasis as a severity indicator: results from the PsoReal study by Radtke, Anna Langenbruch, Kristian Reich, Matthias Augustin, Ines Schäfer

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Assessing adherence factors in patients under topical treatment: development of the Topical Therapy Adherence Questionnaire (TTAQ)

    Assessing adherence factors in patients under topical treatment: development of the Topical Therapy Adherence Questionnaire (TTAQ) by I. Zschocke, Ulrich Mrowietz, Annett Lotzin, Eleni Karakasili, Kristian Reich

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany

    Co-morbidity and Age-related Prevalence of Psoriasis: Analysis of Health Insurance Data in Germany by Matthias Augustin, Kristian Reich, Gerd Glaeske, Ines Schaefer, Marc Alexander Radtke

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey

    Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey by MA Radtke, Kristian Reich, Christine Blome, Stephan Jeff Rustenbach, Matthias Augustin

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Long‐term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic disease

    Long‐term efficacy and safety of secukinumab in the treatment of the multiple manifestations of psoriatic disease by Kristian Reich, Richard B. Warren, Laura C. Coates, Gabriele Di Comite

    Published 2019
    Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Promoter Polymorphisms of the Genes Encoding Tumor Necrosis Factor-α and Interleukin-1β are Associated with Different Subtypes of Psoriasis Characterized by Early and Late Disease Onset

    Promoter Polymorphisms of the Genes Encoding Tumor Necrosis Factor-α and Interleukin-1β are Associated with Different Subtypes of Psoriasis Characterized by Early and Late Disease... by Kristian Reich, Rotraut Mößner, Christine Neumann, Inke R. König, Götz Westphal, Andreas Ziegler

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3)

    Efficacy and safety of ixekizumab for the treatment of moderate-to-severe plaque psoriasis: Results through 108 weeks of a randomized, controlled phase 3 clinical trial (UNCOVER-3) by Andrew Blauvelt, Melinda Gooderham, Lars Iversen, Susan Ball, Lu Zhang, Noah Agada, Kristian Reich

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema

    Epidemiology and Comorbidity in Children with Psoriasis and Atopic Eczema by Matthias Augustin, Marc Alexander Radtke, Gerd Glaeske, Kristian Reich, Enno Christophers, Ines Schaefer, Arnd Jacobi

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Quality of psoriasis care in Germany – results of the national study PsoHealth 2007

    Quality of psoriasis care in Germany – results of the national study PsoHealth 2007 by Matthias Augustin, Kristian Reich, Christine Reich, S. Purwins, Stephan Jeff Rustenbach, Ines Schäfer, Marc Alexander Radtke

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    A 52-Week Trial Comparing Briakinumab with Methotrexate in Patients with Psoriasis

    A 52-Week Trial Comparing Briakinumab with Methotrexate in Patients with Psoriasis by Kristian Reich, Richard Langley, Kim Papp, Jean‐Paul Ortonne, Kristina Unnebrink, Martin Kaul, Joaquin Valdes

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest

    Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest by Kristian Reich, Ulrich Mrowietz, Marc Alexander Radtke, Diamant Thaçi, Stephan Jeff Rustenbach, C. Spehr, Matthias Augustin

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Response of Psoriasis to Interleukin-10 is Associated with Suppression of Cutaneous Type 1 Inflammation, Downregulation of the Epidermal Interleukin-8/CXCR2 Pathway and Normalization of Keratinocyte Maturation

    Response of Psoriasis to Interleukin-10 is Associated with Suppression of Cutaneous Type 1 Inflammation, Downregulation of the Epidermal Interleukin-8/CXCR2 Pathway and Normalizati... by Kristian Reich, Volker Blaschke, Constance Maurer, Undine Lippert, Christine Neumann, Claus Garbe, Peter Middel, Götz Westphal

    Published 2001
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Combined Analysis of Polymorphisms of the Tumor Necrosis Factor-α and Interleukin-10 Promoter Regions and Polymorphic Xenobiotic Metabolizing Enzymes in Psoriasis

    Combined Analysis of Polymorphisms of the Tumor Necrosis Factor-α and Interleukin-10 Promoter Regions and Polymorphic Xenobiotic Metabolizing Enzymes in Psoriasis by Kristian Reich, Sabine Zipprich, Thomas Fuchs, Christine Neumann, Götz Westphal, Thomas Schulz, Michael Müller, Ernst Hallier

    Published 1999
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: